Chengchen Lufei

Title: Chengchen Lufei - Innovator in Pharmaceutical Combinations

Introduction

Chengchen Lufei is a notable inventor based in Hangzhou, China, recognized for his contributions to the field of pharmaceuticals. With a focus on innovative drug combinations, he has made significant strides in the treatment of complex medical conditions.

Latest Patents

Chengchen Lufei holds a patent for a pharmaceutical combination of pimozide and methotrexate, which is disclosed for its use in treating rheumatoid arthritis. This combination includes methotrexate, its pharmaceutically acceptable salts, and pimozide, also in its acceptable forms, showcasing his commitment to advancing therapeutic options for patients.

Career Highlights

Lufei's career is marked by his work at Generos Biopharma Ltd., where he has been instrumental in developing innovative pharmaceutical solutions. His expertise in drug formulation and combination therapies has positioned him as a key player in the biopharmaceutical industry.

Collaborations

Throughout his career, Chengchen has collaborated with esteemed colleagues, including Xin-Yuan Fu and Xinyu Liu. These partnerships have fostered a collaborative environment that enhances research and development efforts within the company.

Conclusion

Chengchen Lufei's contributions to pharmaceutical innovations reflect his dedication to improving patient outcomes through effective drug combinations. His work continues to inspire advancements in the field, making